Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Intended Joint Offer for Subscription

23 Aug 2019 16:23

RNS Number : 1233K
Maven Income and Growth VCT 3 PLC
23 August 2019
 

Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC

(the "Companies")

 

Statement re Intended Joint Offers for Subscription

 

The Directors of the Companies are pleased to announce the intention to raise up to £15 million, in aggregate, by way of joint offers for subscription of new ordinary shares (the "Offers"), with shares to be issued in the 2019/20 and 2020/21 tax years.

The Boards are confident that, given the strength of the current pipeline of investment opportunities, the Companies' investment manager, Maven Capital Partners UK LLP, will continue to be able identify and complete VCT qualifying transactions in line with each Company's investment strategy.

A prospectus with full details of the Offers is intended for publication in Autumn 2019. A further announcement will be made when the prospectus is available.

An applicant will be able to invest in one or both of the Offers, in accordance with the terms to be set out in the prospectus for the Offers and subject to the relevant Offer selected remaining open.

It is anticipated that the Offers will remain open until no later than 3 April 2020 in respect of the 2019/20 tax year and until 30 April 2020 in respect of the 2020/21 tax year, unless an Offer is fully subscribed at an earlier date and subject to each Board's right to close or extend the relevant Offer at any time.

 

On behalf of the Boards

Maven Capital Partners UK LLP

Secretary

23 August 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STREASPDAAFNEFF
Date   Source Headline
2nd Oct 202012:41 pmRNSIssue of Equity
29th Sep 20204:49 pmRNSStatement re Dividend Investment Scheme
1st Sep 20204:35 pmRNSTransaction in Own Shares
28th Aug 20202:38 pmRNSHalf-year Report
26th Aug 20205:26 pmRNSTransaction in Own Shares
20th Aug 202011:38 amRNSStatement re NAV, Interim Dividend and DIS
20th Aug 202011:29 amRNSDirector Declaration
9th Jul 202010:00 amRNSIssue of Equity
8th Jun 20209:36 amRNSAllotment Update
21st May 202012:17 pmRNSResult of AGM
15th May 20204:10 pmRNSNet Asset Value(s)
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
21st Apr 20206:24 pmRNSAnnual Financial Report
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update and Suspension of DIS
20th Mar 20204:57 pmRNSTransaction in Own Shares
28th Feb 20204:56 pmRNSTransaction in Own Shares
24th Feb 20204:35 pmRNSStatement re Net Asset Value and Proposed Dividend
11th Feb 20205:04 pmRNSDirector/PDMR Shareholding
11th Feb 20205:02 pmRNSDirector/PDMR Shareholding
11th Feb 20204:24 pmRNSIssue of Equity
6th Feb 20203:39 pmRNSStatement re Offer for Subscription
18th Dec 20192:14 pmRNSDirectorate Change
18th Dec 20192:09 pmRNSMerger Update: Approval of Scheme
10th Dec 201912:30 pmRNSResult of General Meeting
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
14th Nov 20196:20 pmRNSStatement re Proposed Merger
7th Nov 20192:11 pmRNSNet Asset Value(s)
4th Oct 201911:30 amRNSDirector/PDMR Shareholding
4th Oct 201910:22 amRNSIssue of Equity
1st Oct 201912:34 pmRNSNet Asset Value(s)
20th Sep 201912:44 pmRNSHalf-year Report
19th Sep 20193:46 pmRNSTransaction in Own Shares
17th Sep 20193:00 pmRNSTransaction in Own Shares
28th Aug 20192:59 pmRNSStatement re Possible Merger
27th Aug 20194:38 pmRNSStatement re NAV and Interim Dividend
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
21st Aug 20194:14 pmRNSStatement re share premium account cancellation
21st May 20194:04 pmRNSTransaction in Own Shares
15th May 20195:02 pmRNSNet Asset Value(s)
15th May 20192:08 pmRNSResult of AGM
5th Apr 20193:25 pmRNSAnnual Financial Report
12th Mar 20192:52 pmRNSTransaction in Own Shares
28th Feb 20194:03 pmRNSNet Asset Value(s)
4th Dec 20184:42 pmRNSTransaction in Own Shares
27th Nov 20183:15 pmRNSTransaction in Own Shares
22nd Nov 20183:14 pmRNSTransaction in Own Shares
19th Nov 201811:45 amRNSDirector/PDMR Shareholding
19th Nov 201811:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.